Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

The key to fibrinolysis and thrombolysis

Roger Lijnen, Désiré Collen

09-09-2025

https://doi.org/10.4081/btvb.2025.368

222

PDF: 52

HTML: 34
Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)

Daniela Poli, Riccardo Tartaglia, Doris Barcellona , Paolo Bucciarelli , Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Vincenzo Toschi, Sophie Testa, Alessandro Squizzato

21-03-2023

https://doi.org/10.4081/btvb.2023.59

634

PDF: 244
Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism?

Simon Noble

16-05-2024

https://doi.org/10.4081/btvb.2024.125

1274

PDF: 305
Restrained glycoprotein VI-induced platelet signaling by tyrosine protein phosphatases independent of phospholipase Cγ2

Jingnan Huang, Delia I. Fernández, Jinmi Zou, Xueqing Wang, Johan W.M. Heemskerk, Ángel García

11-10-2023

https://doi.org/10.4081/btvb.2023.93

484

PDF: 194
Hemostasis and the kidney: an unforeseen initial opportunity to create a small research group that grew into an institute

Carlamaria Zoja, Ariela Benigni, Giuseppe Remuzzi

30-06-2025

https://doi.org/10.4081/btvb.2025.190

279

PDF: 49

Supplementary: 12
A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients

Pantep Angchaisuksiri, Wolfram Ruf, Jeffrey Weitz, Sam Schulman, Guy A. Young

01-07-2025

https://doi.org/10.4081/btvb.2025.188

1022

PDF: 147

HTML: 0
Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

Paolo Simioni, Vittorio Pengo, Paolo Prandoni

07-11-2022

https://doi.org/10.4081/btvb.2022.52

2122

PDF: 249
The subtle red line between combating and resolving inflammation in the cardiovascular disease, a “silent sniper”

Ciarán Kennedy, Luke J. Conroy, Braden Millar, Monica de Gaetano

30-06-2025

https://doi.org/10.4081/btvb.2025.187

845

PDF: 156
Circulating albumin-to-fibrinogen ratio may be a risk indicator for venous thromboembolism: findings from a population-based prospective cohort study

Setor K. Kunutsor, Sudhir Kurl, Ari Voutilainen, Jari Laukkanen

14-07-2022

https://doi.org/10.4081/btvb.2022.36

1098

PDF: 245
Plasma fibrinogen levels and all-cause and cause-specific mortality in an Italian adult population: results from the Moli-sani study

Roberta Parisi, Simona Costanzo, Romy de Laat-Kremers, Augusto Di Castelnuovo, Amalia De Curtis, Teresa Panzera, Mariarosaria Persichillo, Chiara Cerletti, Giovanni de Gaetano, Maria Benedetta Donati, Licia Iacoviello, Bas de Laat , for the Moli-sani Study Investigators

27-01-2023

https://doi.org/10.4081/btvb.2023.46

1722

PDF: 438

APPENDIX: 113
Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles

Nadim Tawil, Lata Adnani, Janusz Rak

16-05-2024

https://doi.org/10.4081/btvb.2024.109

516

PDF: 277
On the impact of generative artificial intelligence on peer review

Giovanni de Gaetano, Chiara Cerletti, Augusto Di Castelnuovo

03-03-2025

https://doi.org/10.4081/btvb.2025.176

764

PDF: 254
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis

Robert Parambi, Nicole Ziliotto, Francesco Bernardi , Marcello Baroni , Richard W Browne , Dejan Jakimovski, Bianca Weinstock-Guttman, Robert Zivadinov, Murali Ramanathan

17-10-2022

https://doi.org/10.4081/btvb.2022.41

2325

PDF: 276

Supplementary Files: 68
Unveiling the “common soil” of cardiovascular disease and cancer

Licia Iacoviello, Maria Benedetta Donati

24-02-2025

https://doi.org/10.4081/btvb.2025.167

813

PDF: 243
The evolution of hemostasis genetics: from monogenic disorders to complex traits. A historical perspective

Augusto Di Castelnuovo

01-07-2025

https://doi.org/10.4081/btvb.2025.184

835

PDF: 141
The Lefoulon Delalande Foundation honors the lymphatic vascular system

Anne Eichmann

26-10-2023

https://doi.org/10.4081/btvb.2023.99

2408

PDF: 207
Anticoagulation in obese patients: challenges and strategies

Alice Lipari, Esmeralda Capristo, Antonietta Ferretti, Erica De Candia

18-09-2025

https://doi.org/10.4081/btvb.2025.174

172

PDF: 32

HTML: 22
Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

Samantha Pasca, Cristina Santoro, Chiara Ambaglio, Marisanta Napolitano, Marta Milan, Letizia Natali, Silvia Nannizzi, Filippo Mori, Paolo Simioni, Ezio Zanon

23-05-2022

https://doi.org/10.4081/btvb.2022.12

5084

PDF: 328
Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators

12-10-2023

https://doi.org/10.4081/btvb.2023.92

858

PDF: 256
Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

Giovanni de Gaetano

29-10-2024

https://doi.org/10.4081/btvb.2024.156

1481

PDF: 288

Appendix: 199
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

Marco P. Donadini, Walter Ageno

15-04-2022

https://doi.org/10.4081/btvb.2022.22

2080

PDF: 560
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

Ang Li, Emily Zhou

16-05-2024

https://doi.org/10.4081/btvb.2024.108

920

PDF: 446
The use of creatine and the development of deep vein thrombosis. A scoping review

Kartik Akkihal, Thomas Varkey, James Kelbert

18-11-2024

https://doi.org/10.4081/btvb.2024.142

4298

PDF: 332

Supplementary: 118
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

22-03-2022

https://doi.org/10.4081/btvb.2022.10

1176

PDF: 380

APPENDIX: 77
Blood platelets, prostaglandins and aspirin: a historical and personal rereading

Giovanni de Gaetano, Chiara Cerletti

13-03-2024

https://doi.org/10.4081/btvb.2024.121

1368

PDF: 241
SISET50: trajectories of hemostasis and thrombosis in Italy 1970-2020

Giovanni de Gaetano, Maria Benedetta Donati, Americo Bonanni

17-01-2025

https://doi.org/10.4081/btvb.2025.170

1056

PDF: 224
Platelet distribution width is associated with cardiovascular mortality in an adult general population

Benedetta Izzi, Simona Costanzo, Alessandro Gialluisi, Amalia De Curtis, Sara Magnacca, Teresa Panzera, Augusto Di Castelnuovo, Maria Benedetta Donati, Chiara Cerletti, Marc F. Hoylaerts, Giovanni de Gaetano, Licia Iacoviello, *on behalf of the Moli-sani Study Investigators

27-09-2023

https://doi.org/10.4081/btvb.2023.83

1984

PDF: 299

Supplementary Material: 54
Artificial intelligence and machine learning in hemostasis and thrombosis

Paolo Gresele

30-12-2023

https://doi.org/10.4081/btvb.2023.105

2608

PDF: 551
Antithrombotic therapy in idiopathic infertility

Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso

03-10-2024

https://doi.org/10.4081/btvb.2024.126

2079

PDF: 529
The 2024 Nobel prize in Medicine: impact on hemostasis and thrombosis research

Loredana Bury, Marco Malvestiti, Paolo Gresele

19-11-2024

https://doi.org/10.4081/btvb.2024.159

1031

PDF: 234
The night of randomized clinical trials where all patients are black: a need to estimate variability in treatment effects

Giovanni de Gaetano, Chiara Cerletti, Licia Iacoviello, Maria Benedetta Donati

22-03-2022

https://doi.org/10.4081/btvb.2022.24

1856

PDF: 271
2024 EACTS guidelines on perioperative medication in adult cardiac surgery: embracing precision medicine driven by strong evidence-based methodology

Bianca Rocca, Emma Hansson, Milan Milojevic, Anders Jeppsson

01-07-2025

https://doi.org/10.4081/btvb.2025.178

1186

PDF: 191
Venous thromboembolism and mortality in patients with hematological malignancies

Kristen M. Sanfilippo, Tzu-Fei Wang

16-05-2024

https://doi.org/10.4081/btvb.2024.119

816

PDF: 377
It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders

Marialaura Bonaccio, Licia Iacoviello, Maria Benedetta Donati

03-08-2023

https://doi.org/10.4081/btvb.2023.91

1180

PDF: 244
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

16-05-2024

https://doi.org/10.4081/btvb.2024.118

967

PDF: 444
The role of dyslipidemia and gender-related risk factors in the management of patients with abdominal aortic aneurysms: a survey from the Italian Society of Angiology and Vascular Medicine and a call to action

Martina Berteotti, Walter Ageno, Rossella Marcucci, Andrea Stella, Paolo Zamboni, Romeo Martini

30-06-2025

https://doi.org/10.4081/btvb.2025.164

779

PDF: 118
Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

03-08-2023

https://doi.org/10.4081/btvb.2023.90

1463

PDF: 482
Clonal hematopoiesis and inflammation: a link with thrombosis and malignancy

Tiziano Barbui

21-07-2022

https://doi.org/10.4081/btvb.2022.38

2947

PDF: 327
Cancer-associated ischemic stroke: current knowledge and future directions

Ronda Lun, Deborah M. Siegal

16-05-2024

https://doi.org/10.4081/btvb.2024.117

2040

PDF: 630
Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

Sarah Gallitto, Thomas C. Varkey, Jacob Lahti

13-12-2024

https://doi.org/10.4081/btvb.2024.131

1452

PDF: 249
Endothelial cell dysfunction in cancer: a not-so-innocent bystander

Betül Ünlü, Neha Joshi, Jamie M. O'Sullivan

16-05-2024

https://doi.org/10.4081/btvb.2024.116

1443

PDF: 385
The clinical usefulness of measuring thrombin generation

Coenraad H. Hemker

06-03-2023

https://doi.org/10.4081/btvb.2023.62

901

PDF: 391
CS07 | Endothelial dysfunction and impaired angiogenesis in Hermansky-Pudlak syndrome (HPS) type 1: studies with endothelial colony forming cells F. Tondi¹, G. Purgatorio¹, C. Sgromo², E. Giglio¹, E. Petito¹, E. Falcinelli¹, G. Guglielmini¹, A. Follenzi², P. Gresele¹, L. Bury^1*, C. Olgasi^3* | ^*Shared senior authorship; ¹Department of Medicine and Surgery, Section of Internal and Cardiovascular Medicine, University of Perugia; ²Department of Health Sciences, School of Medicine, University of Piemonte Orientale, Novara; ³Department of Translational Medicine, School of Medicine, University of Piemonte Orientale, Novara, Italy

16-09-2025

https://doi.org/10.4081/btvb.2025.204

47
“Living under the sword of Damocles”: a psychological support project for patients with immune thrombocytopenia and their caregivers

Giuseppe Auteri, Laura Ricci, Nicola Vianelli, Barbara Lovrencic

13-03-2025

https://doi.org/10.4081/btvb.2025.161

404

PDF: 136

Appendix A: 41

Appendix B: 48
A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice

Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele

23-05-2022

https://doi.org/10.4081/btvb.2022.19

4724

PDF: 300
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth

16-05-2024

https://doi.org/10.4081/btvb.2024.115

833

PDF: 338
Distal deep vein thrombosis: is there a way out of this dark forest?

Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

04-09-2024

https://doi.org/10.4081/btvb.2024.129

919

PDF: 283
Author's Reply. Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

Giovanni de Gaetano

05-12-2024

https://doi.org/10.4081/btvb.2024.163

622

PDF: 124
Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

16-05-2024

https://doi.org/10.4081/btvb.2024.114

587

PDF: 294
Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial"

Vittorio Pengo

01-07-2025

https://doi.org/10.4081/btvb.2025.179

595

PDF: 152

1 - 50 of 50 items

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy